Inhibitory effect of a new nonsteroidal anti-inflammatory drug, 6-methoxy-4-phenyl-1-(2,2,2-trifluoroethyl)-2-(1H)-quinazolinone, on prostaglandin biosynthesis.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004008:Diclofenac / Q000494:pharmacology; D005260:Female; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis*; D011799:Quinazolines / Q000008:administration & dosage / Q000494:pharmacology*; D052999:Quinazolinones; D011817:Rabbits
D000893:Anti-Inflammatory Agents; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011799:Quinazolines; D052999:Quinazolinones; D004008:Diclofenac; C039449:6-methoxy-4-phenyl-1-(2,2,2-trifluoroethyl)-2-(1H)-quinazolinone; D007213:Indomethacin